<unk>  is an antineoplastic agent that is FDA approved for the treatment of induction of remission and consolidation in patients with acute promyelocytic leukemia (APL) who are refractory to, or have relapsed from, retinoid and [[anthracycline]] chemotherapy, and whose APL is characterized by the presence of the t(15;17) translocation or PML/RAR-alpha gene expression.. There is a Black Box Warning for this drug as shown here.  Common adverse reactions include Most patients experienced some drug-related toxicity, most commonly leukocytosis, gastrointestinal (nausea, vomiting, diarrhea, and abdominal pain), fatigue, edema, hyperglycemia, dyspnea, cough, rash or itching, headaches, and dizziness..
Arsenic trioxide
Arsenic tribromide
Arsenic pentoxide
Beryllium oxide
Carbon tetrachloride
Cadmium oxide
Acetylene tetrabromide
Nitrazine